Compositions and Methods for Treating or Preventing Pneumovirus Infection and Associated Diseases
AssigneeMicrodose Therapeutx, Inc.
InventorsRobert O. Cook, Eugene R. Reynolds, Boris Shekunov, Siead I. Zegar
Life of this patent
Estimating the term…
Abstract
The present invention provides novel crystalline polymorphic forms of MDT-637, in particular, crystalline polymorphic forms with physicochemical properties specifically suited for drug production, amorphous formation, composite form, and methods of preparation thereof. The novel polymorphs described herein are useful for the treatment of respiratory disease, such as disease caused by respiratory syncytial virus.
Claims20
A composition comprising a polymorph of MDT-637.
A method of treating a disease resulting from infection by Paramyxovirinae or Pneumovirinae, comprising administering a compound in an amount effective to treat the subject wherein the compound comprises a polymorph of MDT-637.
A method of treating an infection associated with respiratory syncytial virus, comprising administering a compound in an amount effective to treat the subject wherein the compound comprises a polymorph of MDT-637.
Dependencies are inferred from the claim text.